QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial

BioCryst Pharmaceuticals (BCRX) News Today

→ Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad)
Free BCRX Stock Alerts
$4.43
-0.07 (-1.56%)
(As of 04:37 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
marketbeat.com logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Hits New 12-Month Low at $4.44
marketbeat.com - April 19 at 1:37 PM
morningstar.com logoBioCryst Pharmaceuticals Inc BCRX
morningstar.com - April 17 at 3:12 PM
marketbeat.com logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Trading Up 2.8%
marketbeat.com - April 17 at 1:52 PM
finanznachrichten.de logoBioCryst Pharmaceuticals, Inc.: BioCryst Announces Approval of ORLADEYO (berotralstat) by the Brazilian Health Regulatory Agency
finanznachrichten.de - April 17 at 10:11 AM
markets.businessinsider.com logoBioCryst: Brazilian Health Regulatory Agency Approves ORLADEYO - Quick Facts
markets.businessinsider.com - April 17 at 10:11 AM
MarketBeat logoBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Short Interest Up 5.6% in March
americanbankingnews.com - April 17 at 5:12 AM
finance.yahoo.com logoBioCryst Pharmaceuticals, Inc. (BCRX)
finance.yahoo.com - April 17 at 5:11 AM
finance.yahoo.com logoBioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
finance.yahoo.com - April 17 at 5:11 AM
marketbeat.com logoShort Interest in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Expands By 5.6%
marketbeat.com - April 16 at 2:34 PM
money.usnews.com logoBiocryst Pharmaceuticals Inc.
money.usnews.com - April 16 at 7:37 AM
MarketBeat logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Down 6.3%
americanbankingnews.com - April 14 at 5:14 AM
marketbeat.com logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Down 6.3%
marketbeat.com - April 12 at 3:17 PM
MarketBeat logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Receives "Buy" Rating from Needham & Company LLC
americanbankingnews.com - April 11 at 4:42 AM
marketbeat.com logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Rating Reaffirmed by Needham & Company LLC
marketbeat.com - April 10 at 8:17 AM
marketbeat.com logoBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Bought by Vanguard Group Inc.
marketbeat.com - April 4 at 4:11 AM
globenewswire.com logoBioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - April 3 at 7:00 AM
marketbeat.com logoAssenagon Asset Management S.A. Trims Stock Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
marketbeat.com - April 3 at 4:36 AM
marketbeat.com logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Hits New 12-Month Low at $4.81
marketbeat.com - April 2 at 4:18 PM
globenewswire.com logoBioCryst to Present at Upcoming Investor Conferences
globenewswire.com - March 25 at 4:01 PM
marketbeat.com logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Down 4.7%
marketbeat.com - March 22 at 2:31 PM
marketbeat.com logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Up 3%
marketbeat.com - March 19 at 12:47 PM
finance.yahoo.com logoBCRX Apr 2024 6.000 put
finance.yahoo.com - March 18 at 12:05 AM
finance.yahoo.com logoBCRX Apr 2024 6.000 call
finance.yahoo.com - March 17 at 2:04 PM
ca.finance.yahoo.com logoBCRX Apr 2024 9.000 call
ca.finance.yahoo.com - March 17 at 1:04 AM
ca.finance.yahoo.com logoBCRX Apr 2024 7.000 put
ca.finance.yahoo.com - March 17 at 1:04 AM
finance.yahoo.com logoBCRX Apr 2024 7.000 call
finance.yahoo.com - March 16 at 10:02 AM
finance.yahoo.com logoBCRX Apr 2024 5.000 put
finance.yahoo.com - March 16 at 10:02 AM
marketbeat.com logoJacobs Levy Equity Management Inc. Trims Stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
marketbeat.com - March 15 at 4:16 AM
marketbeat.com logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Sets New 52-Week Low at $4.82
marketbeat.com - March 14 at 3:16 PM
marketbeat.com logoBioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Up 6%
marketbeat.com - March 8 at 1:25 PM
globenewswire.com logoBioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - March 5 at 7:01 AM
marketbeat.com logoBraidwell LP Buys 2,571,100 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
marketbeat.com - March 1 at 10:18 AM
investorplace.com logoHidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects
investorplace.com - March 1 at 8:29 AM
marketbeat.com logoHC Wainwright Comments on BioCryst Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:BCRX)
marketbeat.com - February 29 at 8:53 AM
marketbeat.com logoBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Purchased by Trexquant Investment LP
marketbeat.com - February 29 at 7:46 AM
seekingalpha.com logoBioCryst Pharmaceuticals, Inc. (BCRX) Q4 2023 Earnings Call Transcript
seekingalpha.com - February 28 at 1:20 PM
finance.yahoo.com logoBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 28 at 1:20 PM
marketbeat.com logoBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to Post Q1 2024 Earnings of ($0.19) Per Share, HC Wainwright Forecasts
marketbeat.com - February 28 at 8:39 AM
markets.businessinsider.com logoAnalysts’ Top Healthcare Picks: BioCryst (BCRX), Veracyte (VCYT)
markets.businessinsider.com - February 28 at 8:19 AM
seekingalpha.com logoBioCryst's Revenue Gains Offset By Rising Expenses: A Closer Look
seekingalpha.com - February 27 at 9:00 AM
finance.yahoo.com logoQ4 2023 BioCryst Pharmaceuticals Inc Earnings Call
finance.yahoo.com - February 27 at 7:51 AM
finance.yahoo.com logoBioCryst Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - February 27 at 7:51 AM
marketbeat.com logoConnor Clark & Lunn Investment Management Ltd. Has $3.84 Million Stock Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
marketbeat.com - February 27 at 7:42 AM
fool.com logoBioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
fool.com - February 26 at 5:02 PM
markets.businessinsider.com logoBuy Rating Affirmed for BioCryst Pharmaceuticals on Orladeyo’s Success and Strong Growth Prospects
markets.businessinsider.com - February 26 at 4:22 PM
msn.com logoWhat's Going On With BioCryst Stock After Earnings?
msn.com - February 26 at 4:22 PM
finanznachrichten.de logoBioCryst Pharmaceuticals, Inc.: BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
finanznachrichten.de - February 26 at 11:22 AM
msn.com logoBioCryst Pharmaceuticals reports Q4 results
msn.com - February 26 at 11:22 AM
finance.yahoo.com logoBioCryst Pharmaceuticals Inc (BCRX) Reports Growth in ORLADEYO Revenue and Projects ...
finance.yahoo.com - February 26 at 11:22 AM
globenewswire.com logoBioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
globenewswire.com - February 26 at 7:00 AM
Get BioCryst Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCRX and its competitors with MarketBeat's FREE daily newsletter.

The #1 Opportunity of the decade? (Ad)

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

BCRX Media Mentions By Week

BCRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCRX
News Sentiment
▼
0.62

0.52
▲
Average
Medical
News Sentiment

BCRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCRX Articles
This Week
▼
12

3
▲
BCRX Articles
Average Week

Get BioCryst Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:BCRX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Your Money is Not Safe
American Alternative